Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 3452-3462

  Sakuishi, Kaori ^a,b   Oki, Shinji ^a   Araki, Manabu ^a   Porcelli, Steven A ^c   Miyake, Sachiko ^a   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CD3 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR; CD1 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 15; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; UPREGULATION; ADULT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CLONE; CELL DIFFERENTIATION; COCULTURE; GENE EXPRESSION PROFILING; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD1; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CLONE CELLS; COCULTURE TECHNIQUES; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; INTERLEUKIN-15; INTERLEUKIN-2; INTERLEUKIN-5; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TH2 CELLS; UP-REGULATION;

EID: 35748932380     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.3452     Document Type: Article

References (43)

1. Bendelac, A., M. Bonneville, and J. F. Kearney. 2001. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol. 1: 177-186.
2. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21: 483-513.
3. Wilson, B. S., and T. L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3: 211-222.
4. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
5. Kawano, T., J. Cui, Y. Koezuka, Y. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629.
6. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
7. Duarte, N., M. Stenstrom, S. Campino, M. L. Bergman, M. Lundholm, D. Holmberg, and S. L. Cardell. 2004. Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. J. Immunol. 173: 3112-3118.
8. Terabe, M., J. Swann, E. Ambrosino, P. Sinha, S. Takaku, Y. Hayakawa, D. I. Godfrey, S. Ostrand-Rosenberg, M. J. Smyth, and J. A. Berzofsky. 2005. A nonclassical non-Vα14-Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J. Exp. Med. 202: 1627-1633.
9. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
10. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195: 637-641.
11. Kim, H. Y., H. J. Kim, H. S. Min, S. Kim, W. S. Park, S. H. Park, and D. H. Chung. 2005. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor β1 production. J. Exp. Med. 201: 41-47.
12. Chiba, A., S. Kaieda, S. Oki, T. Yamamura, S. Miyake, and 2005. The involvement of Vα14 NKT cells in the pathogenesis of arthritis in murine models. Arthritis Rheum. 52: 1941-1948.
13. Ohnishi, Y., A. Tsutsumi, D. Goto, S. Itoh, I. Matsumoto, M. Taniguchi, and T. Sumida. 2005. TCR Vα14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis. Clin. Exp. Immunol. 141: 47-53.
14. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
15. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J.-M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171: 1637-1641.
16. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
17. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159: 2240-2249.
18. Schmieg, J., G. Yang, R. W. Franck, and M. Tsuji. 2003. Superior protection against malaria and melanoma metastases by a c-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198: 1631-1641.
19. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature 413: 531-534.
20. Miyake, S., and T. Yamamura. 2005. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune disease. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5: 315-322.
21. Heller, F., I. J. Fuss, E. E. Nieuenhuis, R. S. Blumberg, and W. Strober. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17: 629-638.
22. + NKT lymphocytes are activated memory cells. Eur. J. Immunol. 30: 1544-1550.
23. + NKT cells in germ-free mice. Eur. J. Immunol. 30: 620-625.
24. Matsuda, J. L., L. Gapin, J. L. Baron, S. Sidobre, D. B. Stetson, M. Mohrs, R. M. Locksley, and M. Kronenberg. 2003. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100: 8395-8400.
25. Oki, S., A. Chiba, T. Yamamura, and S. Miyake. 2004. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113: 1631-1640.
26. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1236.
27. Joyce, S., A. S. Woods, J. W. Yewdell, J. R. Bennink, D. De Silva, A. Boesteanu, S. P. Balk, R. J. Cotter, and R. R. Brutkiewicz. 1998. Natural ligand of mouse CD1d1; cellular glycosylphosphatidylinositol. Science 279: 1541-1544.
28. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. Porceli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12: 211-221.
29. Rauch, J., J. E. Gumperz, C. Robinson, M. Skold, C. Roy, D. C. Young, M. Lafler, B. D. Moody, M. B. Brenner, and C. E. Costello. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278: 47508-47515.
30. Zhou, D., J. Mattner, C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
31. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, 3rd, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
32. Thomas, S. Y., R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, and A. D. Luster. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171: 2571-2580.
33. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15: 279-288.
34. Takahashi, K., T. Aranami, M. Endoh, S. Miyake, and T. Yamamura. 2004. The regulatory role of natural killer cells in multiple sclerosis. Brain 127: 1917-1927.
35. van Der Vliet, H. J., N. Nishi, T. D. de Gruijl, B. M. von Blomberg, A. J. van den Eertwegh, H. M. Pinedo, G. Giaccone, and R. J. Scheper. 2000. Human natural killer T cells acquire a memory-active phenotype before birth. Blood 95: 2440-2442.
36. Brigl, M., P. van den Elzen, X. Chen, J. H. Meyers, D. Wu, C.-H. Wong, F. Reddington, P. A. Illarianov, G. S. Besra, M. B. Brenner, and J. E. Gumperz. 2006. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J. Immunol. 176: 3625-3634.
37. Ruckert, R., K. Brandt, A. Braun, H.-G. Hoymann, U. Herz, V. Budagian, H. Durkop, H. Renz, and S. Bulfone-Paus. 2005. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J. Immunol. 174: 5507-5515.
38. + natural killer T cells in bronchial asthma. N. Engl. J. Med. 354: 1117-1129.
39. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167: 43-56.
40. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, and K. Takatsu. 1988. Highly purified murine interleukin (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as eosinophil chemotactic factor. J. Exp. Med. 167: 1737-1742.
41. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190: 783-792.
42. Mallevaey, T., J. P. Zanetta, C. Faveeuw, J. Fontain, E. Maes, F. Platt, M. Capron, M. L. de-Moraes, and F. Trottein. 2006. Activation of invariant NKT cells by the helminth parasite Schistosoma mansoni. J. Immunol. 176: 2476-2485.
43. Porubsky, S., A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H.-J. Grone. 2007. Normal development and function of invariant natural killer T cells in mice with isoglobosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 104: 5977-5982.